Anna Rita Scortechini

1.5k total citations
20 papers, 238 citations indexed

About

Anna Rita Scortechini is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Anna Rita Scortechini has authored 20 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Anna Rita Scortechini's work include Chronic Myeloid Leukemia Treatments (5 papers), Cutaneous lymphoproliferative disorders research (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Anna Rita Scortechini is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Cutaneous lymphoproliferative disorders research (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Anna Rita Scortechini collaborates with scholars based in Italy, Taiwan and Poland. Anna Rita Scortechini's co-authors include Massimo Offidani, Pietro Leoni, Serena Rupoli, Gaia Goteri, Stefano Pulini, Giorgio Filosa, Riccardo Centurioni, Laura Corvatta, Alfredo Giacchetti and Giuliano Brandozzi and has published in prestigious journals such as Blood, Haematologica and Journal of Clinical Medicine.

In The Last Decade

Anna Rita Scortechini

19 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Rita Scortechini Italy 8 105 98 87 76 69 20 238
Sara Barulli Italy 7 110 1.0× 88 0.9× 97 1.1× 57 0.8× 54 0.8× 12 274
Dimas Suárez‐Vilela Spain 6 53 0.5× 79 0.8× 41 0.5× 29 0.4× 49 0.7× 8 174
Kazunari Aoki Japan 11 172 1.6× 29 0.3× 71 0.8× 32 0.4× 101 1.5× 24 302
Ana Batlle Spain 7 45 0.4× 38 0.4× 151 1.7× 51 0.7× 115 1.7× 15 248
S. J. Kim South Korea 7 81 0.8× 38 0.4× 127 1.5× 33 0.4× 123 1.8× 12 280
Bérengère Gruson France 10 166 1.6× 23 0.2× 76 0.9× 56 0.7× 51 0.7× 21 328
Natasha Lewis United States 7 55 0.5× 28 0.3× 84 1.0× 33 0.4× 70 1.0× 20 195
Mahsa Khanlari United States 9 35 0.3× 26 0.3× 103 1.2× 34 0.4× 114 1.7× 28 205
Sébastian Wittnebel France 9 81 0.8× 14 0.1× 80 0.9× 35 0.5× 136 2.0× 19 260
Claudia Castañeda Mexico 8 49 0.5× 37 0.4× 101 1.2× 17 0.2× 154 2.2× 17 241

Countries citing papers authored by Anna Rita Scortechini

Since Specialization
Citations

This map shows the geographic impact of Anna Rita Scortechini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rita Scortechini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rita Scortechini more than expected).

Fields of papers citing papers by Anna Rita Scortechini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Rita Scortechini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rita Scortechini. The network helps show where Anna Rita Scortechini may publish in the future.

Co-authorship network of co-authors of Anna Rita Scortechini

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Rita Scortechini. A scholar is included among the top collaborators of Anna Rita Scortechini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Rita Scortechini. Anna Rita Scortechini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Colomba, Paolo, Giovanni Caocci, Gaetano Giuffrida, et al.. (2024). Gaucher Disease or Acid Sphingomyelinase Deficiency? The Importance of Differential Diagnosis. Journal of Clinical Medicine. 13(5). 1487–1487. 2 indexed citations
2.
3.
Breccia, Massimo, Luigia Luciano, Mario Annunziata, et al.. (2021). Multicenter, Prospective and Retrospective Observational Cohort Study of Ponatinib in Patients with CML in Italy: Primary Analysis of the Oiti Trial. Blood. 138(Supplement 1). 3603–3603. 5 indexed citations
4.
Iurlo, Alessandra, Mario Annunziata, Francesco Albano, et al.. (2019). Multicenter, Prospective and Retrospective Observational Cohort Study of Ponatinib in Patients with CML in Italy: Interim Analysis of the OITI Trial. Blood. 134(Supplement_1). 1652–1652. 4 indexed citations
5.
Minardi, Daniele, Anna Rita Scortechini, Giulio Milanese, Pietro Leoni, & Giovanni Muzzonigro. (2016). Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report. Archivio Italiano di Urologia e Andrologia. 88(1). 62–62. 1 indexed citations
6.
Goteri, Gaia, Pietro Leoni, Giuliano Brandozzi, et al.. (2016). Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides. European Journal of Dermatology. 26(1). 13–20. 9 indexed citations
7.
Svegliati‐Baroni, Gianluca, Massimo Offidani, Gaia Goteri, et al.. (2016). Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splanchnic or Cerebral Venous Thrombosis. Blood. 128(22). 4257–4257. 1 indexed citations
8.
Goteri, Gaia, et al.. (2015). Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosis. Diagnostic Pathology. 10(1). 29–29. 15 indexed citations
9.
Gini, Guido, Michela Sampaolo, Silvia Trappolini, et al.. (2015). A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory. Blood. 126(23). 5109–5109. 4 indexed citations
10.
Capelli, Debora, Martina Chiarucci, Antonella Poloni, et al.. (2014). Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin. Biology of Blood and Marrow Transplantation. 20(9). 1399–1406. 8 indexed citations
11.
Rupoli, Serena, Gaia Goteri, Stefano Pulini, et al.. (2008). Alemtuzumab in Combination with Interferon-α or Gemcitabine in Aggressive and Advanced Cutaneous T-Cell Lymphomas: Report of Preliminary Results. Blood. 112(11). 5000–5000. 4 indexed citations
12.
Pulini, Stefano, Serena Rupoli, Gaia Goteri, et al.. (2008). Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B‐cell lymphomas and comparison with the commonly used therapies. European Journal Of Haematology. 82(3). 184–193. 14 indexed citations
13.
Pulini, Stefano, Serena Rupoli, Gaia Goteri, et al.. (2007). Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas. Haematologica. 92(5). 686–689. 40 indexed citations
14.
Offidani, Massimo, Laura Corvatta, Giuseppe Visani, et al.. (2006). Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.. PubMed. 91(1). 133–6. 62 indexed citations
15.
Goteri, Gaia, Stefano Pulini, Alessandra Filosa, et al.. (2005). Long‐term experience with low‐dose interferon‐α and PUVA in the management of early mycosis fungoides. European Journal Of Haematology. 75(2). 136–145. 44 indexed citations
16.
Offidani, Massimo, Laura Corvatta, Giuseppe Visani, et al.. (2005). Thalidomide, Dexamethasone and Pegylated-Liposomal Doxorubicin (ThaDD) for Untreated Multiple Myeloma Patients Aged over 65 Years.. Blood. 106(11). 2558–2558. 1 indexed citations
17.
Offidani, Massimo, Laura Corvatta, Lara Malerba, et al.. (2004). Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL). Leukemia & lymphoma. 46(2). 233–238. 13 indexed citations
18.
Offidani, Massimo, Laura Corvatta, Lara Malerba, et al.. (2004). Comparison of Two Regimens for the Treatment of Elderly Patients with Acute Lymphoblastic Leukaemia (ALL).. Blood. 104(11). 4490–4490. 4 indexed citations
19.
Grassi, Felice Roberto, et al.. (2004). [Antibacterial effect of Nd:YAG laser in periodontal pockets decontamination: a in vivo study].. PubMed. 53(6). 355–9. 5 indexed citations
20.
Scortechini, Anna Rita, et al.. (1999). Expression of C-MYB and B-MYB Oncogenes on Myelofibrotic Marrow Fibroblasts. Leukemia & lymphoma. 33(3-4). 295–304. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Barulli Breakdown of academic impact, for papers by Dimas Suárez‐Vilela Breakdown of academic impact, for papers by Kazunari Aoki Breakdown of academic impact, for papers by Ana Batlle Breakdown of academic impact, for papers by S. J. Kim Breakdown of academic impact, for papers by Bérengère Gruson Breakdown of academic impact, for papers by Natasha Lewis Breakdown of academic impact, for papers by Mahsa Khanlari Breakdown of academic impact, for papers by Sébastian Wittnebel Breakdown of academic impact, for papers by Claudia Castañeda
Rankless by CCL
2026